Table 1.
Clinicopathological characteristics of patient cohort for which formed TMAs
| n = 128 | |
|---|---|
| Operation age* | 67.77 (45.48–85.41) |
| Sex ratio (M:F) | 112:16 |
| ASA | |
| 1 | 13 (10.2) |
| 2 | 93 (72.4) |
| 3 | 22 (17.3) |
| Tumour site | |
| Lower 1/3 | 46 (35.9) |
| OGJ—S1 | 25 (19.5) |
| OGJ—S2 | 26 (20.3) |
| OGJ—S3 | 31 (24.2) |
| Type | |
| AC | 128 (100) |
| pT or ypT | |
| T1 | 29 (22.7) |
| T2 | 30 (23.4) |
| T3 | 65 (50.8) |
| T4 | 4 (3.1) |
| pN or ypN | |
| N0 | 59 (46.1) |
| N1 | 28 (21.9) |
| N2 | 21 (16.4) |
| N3 | 20 (15.6) |
| pM or ypM | |
| M0 | 125 (97.7) |
| M1 | 3 (2.3) |
| Resection clearance (R0) | 104 (81.3) |
| Vascular invasion | 51 (39.8) |
| Lymphatic invasion | 21 (16.4) |
| Perineural invasion | 17 (13.3) |
| Neoadjuvant chemotherapy | 76 (59.4) |
| Neoadjuvant regime | |
| ECX | 64 (50) |
| EOX | 10 (7.8) |
| ECF | 2 (1.6) |
| Tumour regression grade | |
| 1 | 0 (0) |
| 2 | 11 (8.6) |
| 3 | 10 (7.8) |
| 4 | 29 (22.7) |
| 5 | 26 (20.3) |
| Not assessed | 0 (0) |
| Surgery only | 52 (40.6) |
| Nodal downstaging | 30/76 (39.5) |
Values in parentheses are percentages unless indicated
ASA American Society of Anesthesiologists physical status classification system
* Values in parentheses are range